New Results

Sensitivity of novel SARS-CoV-2 Omicron subvariants, BA.2.11, BA.2.12.1, BA.4 and BA.5 to therapeutic monoclonal antibodies

Daichi Yamasoba, Yusuke Kosugi, Izumi Kimura, Shigeru Fujita, Keiya Uriu, Jumpei Ito, Kei Sato, The Genotype to Phenotype Japan (G2P-Japan) Consortium
doi: https://doi.org/10.1101/2022.05.03.490409

Article usage

Article usage: May 2022 to September 2023

AbstractFullPdf
May 2022111629686407
Jun 202219583711129
Jul 20221654302655
Aug 202233979193
Sep 202238463108
Oct 20222123955
Nov 202283944
Dec 202284326
Jan 202368725
Feb 202337616
Mar 202361120
Apr 202334239
May 20233218
Jun 202316212
Jul 202318317
Aug 202320325
Sep 2023634109
Back to top
Posted May 03, 2022.
Download PDF

Supplementary Material

Email
Sensitivity of novel SARS-CoV-2 Omicron subvariants, BA.2.11, BA.2.12.1, BA.4 and BA.5 to therapeutic monoclonal antibodies
Daichi Yamasoba, Yusuke Kosugi, Izumi Kimura, Shigeru Fujita, Keiya Uriu, Jumpei Ito, Kei Sato, The Genotype to Phenotype Japan (G2P-Japan) Consortium
bioRxiv 2022.05.03.490409; doi: https://doi.org/10.1101/2022.05.03.490409
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area